NCT06907706 Active Living After Cancer: Implementation Within Be Well Acres Homes
| NCT ID | NCT06907706 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 164 participants |
| Start Date | 2023-04-03 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 164 participants in total. It began in 2023-04-03 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research study is to learn more about a physical activity program adapted for cancer survivors.
Eligibility Criteria
Inclusion Criteria: 1. Past diagnosis of invasive cancer, or a caregiver (family or friend) of a participating survivor. 2. No longer receiving treatment for cancer (except hormone therapy or long-term maintenance chemotherapy). 3. Over the age of 18. 4. Screen negative for contraindicating health problems on the adapted Physical Activity Readiness Questionnaire (PAR-Q),79 or screened positive but have approval from a health care provider to participate. 5. Lives in the Acres Homes neighborhood of Houston, Texas or has a home zip code of 77088 or 77091. 6. Able to provide informed consent. Exclusion Criteria: 1. Women who are pregnant (as indicated by self-report). 2. Has participated in the ALAC program within the past year and attended more than 2 group sessions.
Contact & Investigator
Karen Basen-Engquist, BA,MPH,PHD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06907706 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06907706 currently recruiting?
Yes, NCT06907706 is actively recruiting participants. Contact the research team at kbasenen@mdanderson.org for enrollment information.
Where is the NCT06907706 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06907706 clinical trial?
NCT06907706 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Karen Basen-Engquist, BA,MPH,PHD at M.D. Anderson Cancer Center. The trial plans to enroll 164 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.